您的购物车当前为空
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 1,992 | 待询 | |
| 10 mg | ¥ 3,369 | 待询 |
FTISADTSK acetate 相关产品
| 产品描述 | FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |
| 密度 | no data available |
| Sequence Short | FTISADTSK |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度信息 | H2O: 50 mg/mL (48.59 mM), Sonication is recommended. |
评论内容